These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 2904)

  • 1. [Anti-hypertensive action of tenormine in the genetically hypertensive rat].
    Boissier JR; Giudicelli ; Richer C
    Nouv Presse Med; 1975 May; 4(22):1661. PubMed ID: 2904
    [No Abstract]   [Full Text] [Related]  

  • 2. Synergistic effects of atenolol and amlodipine for lowering and stabilizing blood pressure in 2K1C renovascular hypertensive rats.
    Shen FM; Xie HH; Ling G; Xu LP; Su DF
    Acta Pharmacol Sin; 2005 Nov; 26(11):1303-8. PubMed ID: 16225751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta-adrenoreceptor blocking and antihypertensive activity of PP-24, a newly synthesized aryloxypropanolamine derivative.
    Nikam AP; Bodhankar SL; Piplani P; Bansal J; Thakurdesai PA
    J Pharm Pharmacol; 2008 Nov; 60(11):1501-6. PubMed ID: 18957171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular effects of tolamolol (UK-6558), a new beta-adrenoreceptor blocking drug, in pinealectomized hypertensive rats.
    Karppanen H; Lahovaara S; Mattila MJ
    Ann Med Exp Biol Fenn; 1973 Mar; 51(3):104-11. PubMed ID: 4149365
    [No Abstract]   [Full Text] [Related]  

  • 5. The demonstration of atenolol as a beta-adrenoceptor blocking drug in man.
    Harry JD
    Postgrad Med J; 1977; 53 Suppl 3():65-9. PubMed ID: 928268
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hypotensive effect of ICI-66082].
    Arce Gómez E; Aguirre Roux L
    Prensa Med Mex; 1977; 42(3-4):187-93. PubMed ID: 335383
    [No Abstract]   [Full Text] [Related]  

  • 7. The relationship between beta-blockade, hyporeninaemic and hypotensive effect of two beta-blocking agents.
    Amery A; De Plaen JF; Fagard R; Linjen P; Reybrouck T
    Postgrad Med J; 1976; 52 Suppl 4():102-8. PubMed ID: 9626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of a new beta-blocking drug, DL 071-IT, on the myocardial contractile state in the waking dog; a comparison with 9 known beta blockaders].
    Marchetti G; Di Francesco GF; Baldoli E
    Boll Soc Ital Cardiol; 1979; 24(9):1039-43. PubMed ID: 45253
    [No Abstract]   [Full Text] [Related]  

  • 9. Proceedings: The hypoglycaemic action of ICI 66082 (4-(2-hydroxy-3-isopropyl-aminopropoxy) phenyl acetamide) in the rat.
    Furman BL; Tayo FM
    Br J Pharmacol; 1974 Sep; 52(1):143P. PubMed ID: 4155984
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tokolysis and dose-dependent effects of beta-blocking with atenolol in the rabbit].
    Steib L; Czekelius P; Behr J
    Z Geburtshilfe Perinatol; 1982; 186(3):145-9. PubMed ID: 6889791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive effects of nifedipine combined with cardioselective beta-adrenergic receptor antagonism by atenolol.
    Opie LH; Jee L; White D
    Am Heart J; 1982 Sep; 104(3):606-12. PubMed ID: 6126111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why another beta-antagonist?
    Fitzgerald JD
    Postgrad Med J; 1977; 53 Suppl 3():52-7. PubMed ID: 22072
    [No Abstract]   [Full Text] [Related]  

  • 13. The haemodynamic and myocardial contractile effects of celiprolol, atenolol and propranolol in mecamylamine-verapamil pretreated, anaesthetised dogs.
    Smith RD; Barrett JA; Wolf PS; Pruss TP
    Br J Clin Pract Suppl; 1985 Jun; 42():35-43. PubMed ID: 2864075
    [No Abstract]   [Full Text] [Related]  

  • 14. Beta receptor blocking and antiarrhythmic properties of tolamolol.
    Bagwell EE; Custy J; Steen RG; Newman WH
    J Pharmacol Exp Ther; 1974 Dec; 191(3):496-505. PubMed ID: 4154378
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of antihypertensive activity of atenolol and methyldopa at rest and during exercise.
    Magnani B; Ambrosioni E; Costa FV; Malini PL; Magelli C
    Int J Clin Pharmacol Ther Toxicol; 1981 Oct; 19(10):440-4. PubMed ID: 7287240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A stereoselective central hypotensive action of atenolol.
    Pearson AA; Gaffney TE; Walle T; Privitera PJ
    J Pharmacol Exp Ther; 1989 Sep; 250(3):759-63. PubMed ID: 2778713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two useful methods for evaluating antihypertensive drugs in conscious freely moving rats.
    Su DF; Xu LP; Miao CY; Xie HH; Shen FM; Jiang YY
    Acta Pharmacol Sin; 2004 Feb; 25(2):148-51. PubMed ID: 14769201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Atenolol, pindolol and propranolol in essential hypertension: response rate and tolerance].
    Greminger P; Vetter H; Boerlin HJ; Baumgart P; Havelka J; Walger P; Lüscher T; Siegenthaler W; Vetter W
    Schweiz Med Wochenschr; 1982 Dec; 112(50):1831-5. PubMed ID: 7156966
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of moxonidine on the cardiac chronotropic regulation in hypertensive rats SHR-SP].
    Khokhlova ON; Murashov AN; Lavrova LN; Medvedev OS
    Eksp Klin Farmakol; 2001; 64(1):42-5. PubMed ID: 11544803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does beta 1-selective agonistic activity interfere with the antihypertensive efficacy of beta 1-selective blocking agents?
    Leonetti G; Sampieri L; Cuspidi C; Terzoli L; Rupoli L; Fruscio M; Gradnik R; Zanchetti A
    J Hypertens Suppl; 1985 Dec; 3(3):S243-5. PubMed ID: 2908819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.